Andrew Gane profile page

Technology Manager, Diagnostics and Genomics, Cytiva

Andrew is responsible for building the innovation pipeline in collaboration with the R&D and commercial teams. His knowledge and understanding of emerging trends and new applications have been fundamental to developing the product portfolio into workflow-based solutions, with a particular focus on next-generation sequencing (NGS). Andrew has more than 30 years of experience in immunodiagnostics and molecular diagnostics in both lab-based and product development roles.

Got a Question for Andrew Gane?

Get in touch using the contact form linked here and we’ll get back to you shortly

Published Content

Total: 1

Webinar

The Future of Diagnostics: Advancements, Challenges and Opportunities

Advances in molecular and immunodiagnostics are enabling a personalized, high-precision approach to health in many clinical areas. But how will this continue to develop in the next five years?
In this webinar, our panel of industry experts will share insights on the molecular and immunodiagnostics market by looking at the external factors which will have the most significant impact in the next five years.
Our panel will also discuss the key challenges and opportunities facing the diagnostic industry and the developments that are likely to have the most impact on patients.

Drug Discovery

Drug Discovery

Andrew Gane profile page

The Future of Diagnostics: Advancements, Challenges and Opportunities